• Diagnosis​ Info ​and​ ​General​ ​Questions

  Sickle Cell Patients Receiving Hydroxyurea in U.S. Still Face Challenges

  Posted by Sickle Cell Forum Administrator on February 16, 2020 at 10:23 am

  

  SCD patients treated with hydroxyurea still struggle with healthcare expenses, low treatment adherence and high discontinuation rates, an analysis shows. Read more here.

  What do you think of these findings?

  Sickle Cell Forum Administrator replied 4 years, 2 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply